U.S. flag

An official website of the United States government

NM_007294.4(BRCA1):c.5123C>T (p.Ala1708Val) AND Hereditary breast and ovarian cancer syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jan 7, 2020
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000048803.13

Allele description

NM_007294.4(BRCA1):c.5123C>T (p.Ala1708Val)

Gene:
BRCA1:BRCA1 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.31
Genomic location:
Preferred name:
NM_007294.4(BRCA1):c.5123C>T (p.Ala1708Val)
Other names:
p.A1708V:GCG>GTG
HGVS:
  • NC_000017.11:g.43063903G>A
  • NG_005905.2:g.154081C>T
  • NM_007294.3:c.5123C>T
  • NM_007294.4:c.5123C>TMANE SELECT
  • NM_007297.4:c.4982C>T
  • NM_007298.3:c.1811C>T
  • NM_007299.4:c.1811C>T
  • NM_007300.4:c.5186C>T
  • NP_009225.1:p.Ala1708Val
  • NP_009225.1:p.Ala1708Val
  • NP_009228.2:p.Ala1661Val
  • NP_009229.2:p.Ala604Val
  • NP_009230.2:p.Ala604Val
  • NP_009231.2:p.Ala1729Val
  • LRG_292t1:c.5123C>T
  • LRG_292:g.154081C>T
  • LRG_292p1:p.Ala1708Val
  • NC_000017.10:g.41215920G>A
  • NM_007294.2:c.5123C>T
  • NR_027676.2:n.5300C>T
  • p.A1708V
Nucleotide change:
5242C>T
Protein change:
A1661V
Links:
dbSNP: rs28897696
Molecular consequence:
  • NM_007294.3:c.5123C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007294.4:c.5123C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007297.4:c.4982C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007298.3:c.1811C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007299.4:c.1811C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007300.4:c.5186C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_027676.2:n.5300C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Functional consequence:
functionally_normal [Sequence Ontology: SO:0002219] - Comment(s)

Condition(s)

Name:
Hereditary breast and ovarian cancer syndrome (HBOC)
Synonyms:
Hereditary breast and ovarian cancer; Hereditary breast and ovarian cancer syndrome (HBOC)
Identifiers:
MONDO: 0003582; MONDO: MONDO:0003582; MeSH: D061325; MedGen: C0677776; Orphanet: 145; OMIM: PS604370

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000076816Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 7, 2020)
germlineclinical testing

PubMed (14)
[See all records that cite these PMIDs]

SCV000591584Department of Pathology and Laboratory Medicine,Sinai Health System - The Canadian Open Genetics Repository (COGR)
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 27, 2015)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A high-throughput functional complementation assay for classification of BRCA1 missense variants.

Bouwman P, van der Gulden H, van der Heijden I, Drost R, Klijn CN, Prasetyanti P, Pieterse M, Wientjens E, Seibler J, Hogervorst FB, Jonkers J.

Cancer Discov. 2013 Oct;3(10):1142-55. doi: 10.1158/2159-8290.CD-13-0094. Epub 2013 Jul 18.

PubMed [citation]
PMID:
23867111

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.

Pal T, Bonner D, Cragun D, Monteiro AN, Phelan C, Servais L, Kim J, Narod SA, Akbari MR, Vadaparampil ST.

Cancer. 2015 Dec 1;121(23):4173-80. doi: 10.1002/cncr.29645. Epub 2015 Aug 19.

PubMed [citation]
PMID:
26287763
PMCID:
PMC4666784
See all PubMed Citations (16)

Details of each submission

From Invitae, SCV000076816.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (14)

Description

This sequence change replaces alanine with valine at codon 1708 of the BRCA1 protein (p.Ala1708Val). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs28897696, ExAC 0.04%). This variant has been reported in individuals with a personal and/or family history of breast cancer (PMID: 16489001, 18036263, 22034289, 26287763, 27495310), and an individual affected with kidney cancer (PMID: 26689913). In addition, it has been found in an individual with ovarian cancer (Invitae). However, in that individual a pathogenic allele was also identified in BRCA2, which suggests that this c.5123C>T variant was not the primary cause of disease. This variant is also known as 5242C>T (A1708V) in the literature. ClinVar contains an entry for this variant (Variation ID: 37640). Experimental studies have shown conflicting results for the effect of this missense change on BRCA1 structure and function. This variant caused decreased stability and compromised transcriptional activation, phosphopeptide binding (PMID: 20516115), and homology-directed repair activity (PMID: 26689913). However, in a different study, a protein with this missense variant showed normal stability and a relatively smaller decrease in transcriptional activity (PMID: 18036263). Additionally, a study utilizing a saturation genome editing (SGE) method has reported that this variant does not substantially affect BRCA1 protein function (PMID: 30209399). A different missense substitution at this codon (p.Ala1708Glu) has been determined to be pathogenic (PMID: 1157798, 11802208, 15923272, 19404736, 23867111). This suggests that the alanine residue is critical for BRCA1 protein function and that other missense substitutions at this position may also be pathogenic. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Department of Pathology and Laboratory Medicine,Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV000591584.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 2, 2021

Modify your search Search (all fields optional) Clear all
Advanced Search